Glucagon-like peptide-1 (GLP-1) agonists, also called GLP-1 receptor agonists or incretin mimetics, are a class of prescription medications used primarily to manage type 2 diabetes mellitus and, in some formulations, obesity
It is very common, with a global prevalence of 9.6%, and can have many causes, including infection, post-nasal drip, GORD, asthma and laryngopharyngeal reflux (silent or pharyngeal reflux)
2016;22(Suppl 3):1-203.
Patients taking B12 supplements, multivitamins, or receiving B12 injections will naturally show elevated levels
At the highest dose of two 50mg tablets per day, people saw an average weight loss of 13% after 12 weeks